1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015 [consultado Ene 2016]. Disponible en: http://seer.cancer.gov/csr/1975_2013/
2. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford Centre for Evidence-based Medicine – Levels of evidence (March 2009) [consultado Ene 2016]. Disponible en: http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009
3. National Comprehensive Cancer Network. NCCN Guidelines® & Clinical Resources. NCCN categories of evidence and consensus [consultado Ene 2016]. Disponible en: http://www.nccn.org/professionals/physician_gls/categories_of_consensus.asp
4. Guía de consenso nacionales para el estudio y tratamiento de los pacientes con leucemia linfocítica crónica;García Marco;Med Clin (Barc).,2013
5. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines;Hallek;Blood,2008